Ron Sullivan

Ron Sullivan is the current CEO at MEDICAL REVIEW INSTITUTE OF AMERICA. Prior to this, they were the Executive Vice President, Product Line Executive eCOA at ERT from August 2014 to April 2018. In this role, they were responsible for the global ERT eCOA clinical trials solutions business and helped the company achieve growth rates of 25%+ annually. Ron also oversaw the acquisition of one of the largest eCOA market competitors in May 2015.Sullivan also played a role in ERT's successful sale to a new PE firm in Q2 2016. In December 2016, they oversaw the acquisition of a second competitor to expand ERT's eCOA presence beyond Phase 1-4.

Some direct reports include Aja Leichliter - Senior Director & Chief Compliance Officer, Randy Iskowitz - CRO, and Donald Murphy - CTO.